CareMax Inc. (CMAXW)
CareMax Statistics
Share Statistics
CareMax has 3.79M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 3.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.08 and the forward PE ratio is null. CareMax's PEG ratio is 0.
| PE Ratio | -0.08 |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | null |
| PB Ratio | 0.91 |
| P/FCF Ratio | -0.91 |
| PEG Ratio | 0 |
Enterprise Valuation
CareMax has an Enterprise Value (EV) of 482.14M.
| EV / Sales | 0.64 |
| EV / EBITDA | -0.82 |
| EV / EBIT | -10.28 |
| EV / FCF | -7.84 |
Financial Position
The company has a current ratio of 0.42, with a Debt / Equity ratio of 8.01.
| Current Ratio | 0.42 |
| Quick Ratio | 0.42 |
| Debt / Equity | 8.01 |
| Debt / EBITDA | -0.83 |
| Debt / FCF | -8 |
| Interest Coverage | -12.05 |
Financial Efficiency
Return on Equity is -1112.15% and Return on Invested Capital is -117.47%.
| Return on Equity | -1112.15% |
| Return on Assets | -109.63% |
| Return on Invested Capital | -117.47% |
| Revenue Per Employee | $518K |
| Profits Per Employee | $-471.27K |
| Employee Count | 1,450 |
| Asset Turnover | 1.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -863K |
| Effective Tax Rate | 0.13% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.68, so CareMax's price volatility has been higher than the market average.
| Beta | 0.68 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 51.99 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, CareMax had revenue of 751.1M and earned -683.35M in profits. Earnings per share was -183.3.
| Revenue | 751.1M |
| Gross Profit | 13.9M |
| Operating Income | -656.15M |
| Net Income | -683.35M |
| EBITDA | -590.46M |
| EBIT | -629.78M |
| Earnings Per Share (EPS) | -183.3 |
Balance Sheet
The company has 65.53M in cash and 491.93M in debt, giving a net cash position of -426.41M.
| Cash & Cash Equivalents | 65.53M |
| Total Debt | 491.93M |
| Net Cash | -426.41M |
| Retained Earnings | -720.94M |
| Total Assets | 454.04M |
| Working Capital | -406.2M |
Cash Flow
In the last 12 months, operating cash flow was -46.91M and capital expenditures -14.61M, giving a free cash flow of -61.52M.
| Operating Cash Flow | -46.91M |
| Capital Expenditures | -14.61M |
| Free Cash Flow | -61.52M |
| FCF Per Share | -16.5 |
Margins
Gross margin is 1.85%, with operating and profit margins of -87.36% and -90.98%.
| Gross Margin | 1.85% |
| Operating Margin | -87.36% |
| Pretax Margin | -91.09% |
| Profit Margin | -90.98% |
| EBITDA Margin | -78.61% |
| EBIT Margin | -87.36% |
| FCF Margin | -8.19% |
Dividends & Yields
CMAXW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1226.07% |
| FCF Yield | -110.39% |
Analyst Forecast
Currently there are no analyst rating for CMAXW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -7.41 |
| Piotroski F-Score | 3 |